| ZS8 | Name: | (2S)-2-amino-2-methyldec-8-ynoic acid | Formula: | C11 H19 N O2 | SMILES: | NC(C(=O)O)(C)CCCCCC#CC | InChi: | InChI=1S/C11H19NO2/c1-3-4-5-6-7-8-9-11(2,12)10(13)14/h5-9,12H2,1-2H3,(H,13,14)/t11-/m0/s1 | Definition date: | 2016-04-06 | Last modified: | 2023-11-03 | Release date: | 2016-10-19 | Identifier: | (2S)-2-amino-2-methyldec-8-ynoic acid |
|
| VU8 | Name: | N-{2-[5-chloro-2-(3-chloro-5-cyanophenoxy)phenoxy]ethyl}-N-methylprop-2-enamide | Formula: | C19 H16 Cl2 N2 O3 | SMILES: | Clc1cc(OCCN(C)C(=O)C=C)c(Oc2cc(C#N)cc(Cl)c2)cc1 | InChi: | InChI=1S/C19H16Cl2N2O3/c1-3-19(24)23(2)6-7-25-18-11-14(20)4-5-17(18)26-16-9-13(12-22)8-15(21)10-16/h3-5,8-11H,1,6-7H2,2H3 | Definition date: | 2023-09-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-{2-[5-chloro-2-(3-chloro-5-cyanophenoxy)phenoxy]ethyl}-N-methylprop-2-enamide |
|
| OGO | Name: | 4-[3-(2-methoxyphenoxy)azetidine-1-carbonyl]quinolin-2(1H)-one | Formula: | C20 H18 N2 O4 | SMILES: | O=C(C1=CC(=O)Nc2ccccc21)N1CC(Oc2ccccc2OC)C1 | InChi: | InChI=1S/C20H18N2O4/c1-25-17-8-4-5-9-18(17)26-13-11-22(12-13)20(24)15-10-19(23)21-16-7-3-2-6-14(15)16/h2-10,13H,11-12H2,1H3,(H,21,23) | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 4-[3-(2-methoxyphenoxy)azetidine-1-carbonyl]quinolin-2(1H)-one |
|
| Q45 | Name: | 2-[(2S)-2-{2-[(methanesulfonyl)amino]ethyl}piperidin-1-yl]-N-(pyridin-3-yl)acetamide | Formula: | C15 H24 N4 O3 S | SMILES: | O=C(CN1CCCCC1CCNS(C)(=O)=O)Nc1cccnc1 | InChi: | InChI=1S/C15H24N4O3S/c1-23(21,22)17-9-7-14-6-2-3-10-19(14)12-15(20)18-13-5-4-8-16-11-13/h4-5,8,11,14,17H,2-3,6-7,9-10,12H2,1H3,(H,18,20)/t14-/m0/s1 | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-[(2S)-2-{2-[(methanesulfonyl)amino]ethyl}piperidin-1-yl]-N-(pyridin-3-yl)acetamide |
|
| PAQ | Name: | 2-OXY-4-HYDROXY-5-(2-HYDRAZINOPYRIDINE)PHENYLALANINE | Formula: | C14 H16 N4 O4 | SMILES: | O=C(O)C(N)CC2C=C(NNc1ncccc1)C(O)=CC2=O | InChi: | InChI=1S/C14H16N4O4/c15-9(14(21)22)5-8-6-10(12(20)7-11(8)19)17-18-13-3-1-2-4-16-13/h1-4,6-9,17,20H,5,15H2,(H,16,18)(H,21,22)/t8-,9+/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | 3-[(1R)-4-hydroxy-6-oxo-3-(2-pyridin-2-ylhydrazino)cyclohexa-2,4-dien-1-yl]-L-alanine |
|
| ZSC | Name: | 5-[methyl(methylsulfonyl)amino]benzene-1,3-dicarboxylic acid | Formula: | C10 H11 N O6 S | SMILES: | O=S(=O)(N(c1cc(cc(c1)C(=O)O)C(=O)O)C)C | InChi: | InChI=1S/C10H11NO6S/c1-11(18(2,16)17)8-4-6(9(12)13)3-7(5-8)10(14)15/h3-5H,1-2H3,(H,12,13)(H,14,15) | Definition date: | 2011-12-08 | Last modified: | 2023-11-03 | Release date: | 2012-11-16 | Identifier: | 5-[methyl(methylsulfonyl)amino]benzene-1,3-dicarboxylic acid |
|
| X9Q | Name: | {(2S)-2-[(1S)-1-AMINOETHYL]-4-BENZYL-5-OXO-2,5-DIHYDRO-1H-IMIDAZOL-1-YL}ACETIC ACID | Formula: | C14 H17 N3 O3 | SMILES: | O=C1C(=NC(N1CC(=O)O)C(N)C)Cc2ccccc2 | InChi: | InChI=1S/C14H17N3O3/c1-9(15)13-16-11(7-10-5-3-2-4-6-10)14(20)17(13)8-12(18)19/h2-6,9,13H,7-8,15H2,1H3,(H,18,19)/t9-,13-/m0/s1 | Synonyms: | CHROMOPHORE (ALA, PHE, GLY) | Definition date: | 2007-03-22 | Last modified: | 2023-11-03 | Identifier: | {(2S)-2-[(1S)-1-aminoethyl]-4-benzyl-5-oxo-2,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| VUB | Name: | 2-[4-[(4-hydroxyphenyl)methyl]-2-(3-methylbutanimidoyl)-5-oxidanyl-imidazol-1-yl]ethanoic acid | Formula: | C17 H21 N3 O4 | SMILES: | CC(C)CC(=N)c1nc(Cc2ccc(O)cc2)c(O)n1CC(O)=O | InChi: | InChI=1S/C17H21N3O4/c1-10(2)7-13(18)16-19-14(17(24)20(16)9-15(22)23)8-11-3-5-12(21)6-4-11/h3-6,10,18,21,24H,7-9H2,1-2H3,(H,22,23)/b18-13- | Definition date: | 2023-04-05 | Last modified: | 2023-11-03 | Release date: | 2023-04-12 | Identifier: | 2-[4-[(4-hydroxyphenyl)methyl]-2-(3-methylbutanimidoyl)-5-oxidanyl-imidazol-1-yl]ethanoic acid |
|
| XPL | Name: | N~6~-[(3R,5R)-5-amino-3-methyl-D-prolyl]-L-lysine | Formula: | C12 H24 N4 O3 | SMILES: | O=C(NCCCCC(C(=O)O)N)C1NC(N)CC1C | InChi: | InChI=1S/C12H24N4O3/c1-7-6-9(14)16-10(7)11(17)15-5-3-2-4-8(13)12(18)19/h7-10,16H,2-6,13-14H2,1H3,(H,15,17)(H,18,19)/t7-,8+,9-,10-/m1/s1 | Synonyms: | 4-amino reduced pyrrolysine | Definition date: | 2014-07-30 | Last modified: | 2023-11-03 | Identifier: | N~6~-[(3R,5R)-5-amino-3-methyl-D-prolyl]-L-lysine |
|
| PAT | Name: | ALPHA-PHOSPHONO-TRYPTOPHAN | Formula: | C11 H13 N2 O5 P | SMILES: | O=C(O)C(N)(P(=O)(O)O)Cc2c1ccccc1nc2 | InChi: | InChI=1S/C11H13N2O5P/c12-11(10(14)15,19(16,17)18)5-7-6-13-9-4-2-1-3-8(7)9/h1-4,6,13H,5,12H2,(H,14,15)(H2,16,17,18) | Definition date: | 2001-03-12 | Last modified: | 2023-11-03 | Identifier: | alpha-phosphono-L-tryptophan |
|
| TRX | Name: | 6-HYDROXYTRYPTOPHAN | Formula: | C11 H12 N2 O3 | SMILES: | O=C(O)C(N)Cc2c1ccc(O)cc1nc2 | InChi: | InChI=1S/C11H12N2O3/c12-9(11(15)16)3-6-5-13-10-4-7(14)1-2-8(6)10/h1-2,4-5,9,13-14H,3,12H2,(H,15,16)/t9-/m0/s1 | Definition date: | 2001-10-29 | Last modified: | 2023-11-03 | Identifier: | 6-hydroxy-L-tryptophan |
|
| OGV | Name: | 2-(3-chlorophenyl)-N-[(4S)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]acetamide | Formula: | C14 H11 Cl N4 O | SMILES: | Clc1cccc(c1)CC(=O)Nc1nnc2ccccn21 | InChi: | InChI=1S/C14H11ClN4O/c15-11-5-3-4-10(8-11)9-13(20)16-14-18-17-12-6-1-2-7-19(12)14/h1-8H,9H2,(H,16,18,20) | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-[(4S)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]acetamide |
|
| TDF | Name: | 4-(trifluoromethyl)-D-phenylalanine | Formula: | C10 H10 F3 N O2 | SMILES: | FC(F)(F)c1ccc(cc1)CC(C(=O)O)N | InChi: | InChI=1S/C10H10F3NO2/c11-10(12,13)7-3-1-6(2-4-7)5-8(14)9(15)16/h1-4,8H,5,14H2,(H,15,16)/t8-/m1/s1 | Definition date: | 2011-09-15 | Last modified: | 2023-11-03 | Identifier: | 4-(trifluoromethyl)-D-phenylalanine |
|
| XPR | Name: | (2S,3aS,6R,7aS)-6-(sulfooxy)octahydro-1H-indole-2-carboxylic acid | Formula: | C9 H15 N O6 S | SMILES: | O=S(=O)(O)OC1CCC2CC(C(=O)O)NC2C1 | InChi: | InChI=1S/C9H15NO6S/c11-9(12)8-3-5-1-2-6(4-7(5)10-8)16-17(13,14)15/h5-8,10H,1-4H2,(H,11,12)(H,13,14,15)/t5-,6+,7-,8-/m0/s1 | Definition date: | 2010-11-05 | Last modified: | 2023-11-03 | Identifier: | (2S,3aS,6R,7aS)-6-(sulfooxy)octahydro-1H-indole-2-carboxylic acid |
|
| O1I | Name: | (2S)-2-(3-chlorophenyl)-3-hydroxy-N-(4-methylpyridin-3-yl)propanamide | Formula: | C15 H15 Cl N2 O2 | SMILES: | O=C(Nc1cnccc1C)C(CO)c1cccc(Cl)c1 | InChi: | InChI=1S/C15H15ClN2O2/c1-10-5-6-17-8-14(10)18-15(20)13(9-19)11-3-2-4-12(16)7-11/h2-8,13,19H,9H2,1H3,(H,18,20)/t13-/m1/s1 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (2S)-2-(3-chlorophenyl)-3-hydroxy-N-(4-methylpyridin-3-yl)propanamide |
|
| Q4F | Name: | 1-{(1S,4S)-5-[(3-chlorophenyl)methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl}ethan-1-one | Formula: | C14 H17 Cl N2 O | SMILES: | CC(=O)N1CC2CC1CN2Cc1cccc(Cl)c1 | InChi: | InChI=1S/C14H17ClN2O/c1-10(18)17-9-13-6-14(17)8-16(13)7-11-3-2-4-12(15)5-11/h2-5,13-14H,6-9H2,1H3/t13-,14-/m0/s1 | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 1-{(1S,4S)-5-[(3-chlorophenyl)methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl}ethan-1-one |
|
| PPN | Name: | PARA-NITROPHENYLALANINE | Formula: | C9 H10 N2 O4 | SMILES: | [O-][N+](=O)c1ccc(cc1)CC(N)C(=O)O | InChi: | InChI=1S/C9H10N2O4/c10-8(9(12)13)5-6-1-3-7(4-2-6)11(14)15/h1-4,8H,5,10H2,(H,12,13)/t8-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | 4-nitro-L-phenylalanine |
|
| XA6 | Name: | (2S)-3-(4-aminocarbonylphenyl)-2-azanyl-propanoic acid | Formula: | C10 H12 N2 O3 | SMILES: | N[CH](Cc1ccc(cc1)C(N)=O)C(O)=O | InChi: | InChI=1S/C10H12N2O3/c11-8(10(14)15)5-6-1-3-7(4-2-6)9(12)13/h1-4,8H,5,11H2,(H2,12,13)(H,14,15)/t8-/m0/s1 | Definition date: | 2021-04-01 | Last modified: | 2023-11-03 | Release date: | 2021-12-15 | Identifier: | (2~{S})-3-(4-aminocarbonylphenyl)-2-azanyl-propanoic acid |
|
| ZT1 | Name: | N~6~-[(1-methyl-1H-imidazol-5-yl)methyl]-N~6~-propan-2-yl-L-lysine | Formula: | C14 H26 N4 O2 | SMILES: | Cn1cncc1CN(CCCCC(N)C(=O)O)C(C)C | InChi: | InChI=1S/C14H26N4O2/c1-11(2)18(9-12-8-16-10-17(12)3)7-5-4-6-13(15)14(19)20/h8,10-11,13H,4-7,9,15H2,1-3H3,(H,19,20)/t13-/m0/s1 | Definition date: | 2021-05-28 | Last modified: | 2023-11-03 | Release date: | 2021-07-21 | Identifier: | N~6~-[(1-methyl-1H-imidazol-5-yl)methyl]-N~6~-propan-2-yl-L-lysine |
|
| Q4R | Name: | N~2~-methyl-N-(4-methylpyridin-3-yl)-N~2~-(quinoline-8-sulfonyl)glycinamide | Formula: | C18 H18 N4 O3 S | SMILES: | O=C(Nc1cnccc1C)CN(C)S(=O)(=O)c1cccc2cccnc21 | InChi: | InChI=1S/C18H18N4O3S/c1-13-8-10-19-11-15(13)21-17(23)12-22(2)26(24,25)16-7-3-5-14-6-4-9-20-18(14)16/h3-11H,12H2,1-2H3,(H,21,23) | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N~2~-methyl-N-(4-methylpyridin-3-yl)-N~2~-(quinoline-8-sulfonyl)glycinamide |
|
| S4X | Name: | (4S)-6-chloro-2-(2-{[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]amino}-2-oxoethyl)-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide | Formula: | C31 H33 Cl N4 O3 | SMILES: | OC12CC3CC(CC(C3)(C2)NC(=O)CN2Cc3ccc(Cl)cc3C(C2)C(=O)Nc2cncc3ccccc32)C1 | InChi: | InChI=1S/C31H33ClN4O3/c32-23-6-5-22-15-36(17-28(37)35-30-9-19-7-20(10-30)12-31(39,11-19)18-30)16-26(25(22)8-23)29(38)34-27-14-33-13-21-3-1-2-4-24(21)27/h1-6,8,13-14,19-20,26,39H,7,9-12,15-18H2,(H,34,38)(H,35,37)/t19-,20+,26-,30+,31-/m1/s1 | Definition date: | 2023-08-22 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (4S)-6-chloro-2-(2-{[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]amino}-2-oxoethyl)-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide |
|
| OHC | Name: | 2-[3-(acetamidomethyl)-5-chlorophenyl]-N-(4-methylpyridin-3-yl)acetamide | Formula: | C17 H18 Cl N3 O2 | SMILES: | O=C(Nc1cnccc1C)Cc1cc(CNC(C)=O)cc(Cl)c1 | InChi: | InChI=1S/C17H18ClN3O2/c1-11-3-4-19-10-16(11)21-17(23)8-13-5-14(7-15(18)6-13)9-20-12(2)22/h3-7,10H,8-9H2,1-2H3,(H,20,22)(H,21,23) | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-[3-(acetamidomethyl)-5-chlorophenyl]-N-(4-methylpyridin-3-yl)acetamide |
|
| OHD | Name: | {(4Z)-2-[(1S)-1-aminoethyl]-4-[(3-chloro-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C14 H14 Cl N3 O4 | SMILES: | NC(C)C1=N/C(C(N1CC(O)=O)=O)=Cc2ccc(c(c2)Cl)O | InChi: | InChI=1S/C14H14ClN3O4/c1-7(16)13-17-10(14(22)18(13)6-12(20)21)5-8-2-3-11(19)9(15)4-8/h2-5,7,19H,6,16H2,1H3,(H,20,21)/b10-5-/t7-/m0/s1 | Synonyms: | PEPTIDE DERIVED CHROMOPHORE | Definition date: | 2019-06-25 | Last modified: | 2023-11-03 | Release date: | 2019-08-07 | Identifier: | {(4Z)-2-[(1S)-1-aminoethyl]-4-[(3-chloro-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| O1X | Name: | (2S)-2-(difluoromethoxy)-N-(4-methylpyridin-3-yl)propanamide | Formula: | C10 H12 F2 N2 O2 | SMILES: | O=C(Nc1cnccc1C)C(C)OC(F)F | InChi: | InChI=1S/C10H12F2N2O2/c1-6-3-4-13-5-8(6)14-9(15)7(2)16-10(11)12/h3-5,7,10H,1-2H3,(H,14,15)/t7-/m0/s1 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (2S)-2-(difluoromethoxy)-N-(4-methylpyridin-3-yl)propanamide |
|
| ZT6 | Name: | (betaR)-3-chloro-beta-{[tri(propan-2-yl)silyl]oxy}-L-tyrosine | Formula: | C18 H30 Cl N O4 Si | SMILES: | Oc1ccc(cc1Cl)C(O[Si](C(C)C)(C(C)C)C(C)C)C(N)C(=O)O | InChi: | InChI=1S/C18H30ClNO4Si/c1-10(2)25(11(3)4,12(5)6)24-17(16(20)18(22)23)13-7-8-15(21)14(19)9-13/h7-12,16-17,21H,20H2,1-6H3,(H,22,23)/t16-,17+/m0/s1 | Definition date: | 2023-03-30 | Last modified: | 2023-11-03 | Release date: | 2023-06-21 | Identifier: | (betaR)-3-chloro-beta-{[tri(propan-2-yl)silyl]oxy}-L-tyrosine |
|